THE PENNANT GROUP, INC. Proceeds from Long-term Lines of Credit
THE PENNANT GROUP, INC. (PNTG) reported Proceeds from Long-term Lines of Credit of $218.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLongTermLinesOfCredit · last filed 2026-08-05
- THE PENNANT GROUP, INC. proceeds from long-term lines of credit for the quarter ending 2026-06-30 was $129.50M, a 90.44% increase year-over-year.
- THE PENNANT GROUP, INC. proceeds from long-term lines of credit for the quarter ending 2026-03-31 was $88.50M, a 8.29% decline year-over-year.
- THE PENNANT GROUP, INC. proceeds from long-term lines of credit for the quarter ending 2025-12-31 was $129.50M.
- THE PENNANT GROUP, INC. proceeds from long-term lines of credit for the quarter ending 2025-09-30 was $79.00M, a 54.99% decline year-over-year.
- THE PENNANT GROUP, INC. proceeds from long-term lines of credit for fiscal 2025 was $373.00M, a 20.52% increase from fiscal 2024.
- THE PENNANT GROUP, INC. proceeds from long-term lines of credit for fiscal 2024 was $309.50M, a 70.05% increase from fiscal 2023.
- THE PENNANT GROUP, INC. proceeds from long-term lines of credit for fiscal 2023 was $182.00M, a 40.54% increase from fiscal 2022.
- THE PENNANT GROUP, INC. proceeds from long-term lines of credit for fiscal 2022 was $129.50M, a 3.19% increase from fiscal 2021.
| Period end | Proceeds from Long-term Lines of Credit 3 month | Proceeds from Long-term Lines of Credit 6 month | Proceeds from Long-term Lines of Credit 9 month | Proceeds from Long-term Lines of Credit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $129.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $218.00M 10-Q · filed 2026-08-05 | $347.50M derived: sum of 3 quarters · filed 2026-08-05 | $426.50M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $88.50M 10-Q · filed 2026-05-06 | $218.00M derived: sum of 2 quarters · filed 2026-05-06 | $297.00M derived: sum of 3 quarters · filed 2026-05-06 | $365.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $129.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $208.50M derived: sum of 2 quarters · filed 2026-02-26 | $276.50M derived: sum of 3 quarters · filed 2026-08-05 | $373.00M 10-K · filed 2026-02-26 |
| 2025-09-30 | $79.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $147.00M derived: sum of 2 quarters · filed 2026-08-05 | $243.50M 10-Q · filed 2025-11-05 | $243.50M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $68.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $164.50M 10-Q · filed 2026-08-05 | $164.50M derived: sum of 3 quarters · filed 2026-08-05 | $340.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $96.50M 10-Q · filed 2026-05-06 | $96.50M derived: sum of 2 quarters · filed 2026-05-06 | $272.00M derived: sum of 3 quarters · filed 2026-05-06 | $337.00M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $175.50M derived: sum of 2 quarters · filed 2026-02-26 | $240.50M derived: sum of 3 quarters · filed 2026-02-26 | $309.50M 10-K · filed 2026-02-26 |
| 2024-09-30 | $175.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $240.50M derived: sum of 2 quarters · filed 2025-11-05 | $309.50M 10-Q · filed 2025-11-05 | $360.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $65.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $134.00M 10-Q · filed 2025-08-06 | $184.50M derived: sum of 3 quarters · filed 2026-02-26 | $222.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $69.00M 10-Q · filed 2025-05-06 | $119.50M derived: sum of 2 quarters · filed 2026-02-26 | $157.00M derived: sum of 3 quarters · filed 2026-02-26 | $210.50M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $50.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $88.00M derived: sum of 2 quarters · filed 2026-02-26 | $141.50M derived: sum of 3 quarters · filed 2026-02-26 | $182.00M 10-K · filed 2026-02-26 |
| 2023-09-30 | $37.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $91.00M derived: sum of 2 quarters · filed 2024-11-06 | $131.50M 10-Q · filed 2024-11-06 | $179.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $53.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $94.00M 10-Q · filed 2024-08-06 | $141.50M derived: sum of 3 quarters · filed 2025-02-27 | $182.50M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $40.50M 10-Q · filed 2024-05-06 | $88.00M derived: sum of 2 quarters · filed 2025-02-27 | $129.00M derived: sum of 3 quarters · filed 2025-02-27 | $159.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $47.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $88.50M derived: sum of 2 quarters · filed 2025-02-27 | $118.50M derived: sum of 3 quarters · filed 2025-02-27 | $129.50M 10-K · filed 2025-02-27 |
| 2022-09-30 | $41.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $71.00M derived: sum of 2 quarters · filed 2023-11-07 | $82.00M 10-Q · filed 2023-11-07 | $110.50M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $30.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $41.00M 10-Q · filed 2023-08-08 | $69.50M derived: sum of 3 quarters · filed 2024-02-28 | $96.00M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $11.00M 10-Q · filed 2023-05-04 | $39.50M derived: sum of 2 quarters · filed 2024-02-28 | $66.00M derived: sum of 3 quarters · filed 2024-02-28 | $97.50M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $28.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $55.00M derived: sum of 2 quarters · filed 2024-02-28 | $86.50M derived: sum of 3 quarters · filed 2024-02-28 | $125.50M 10-K · filed 2024-02-28 |
| 2021-09-30 | $26.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $58.00M derived: sum of 2 quarters · filed 2022-11-07 | $97.00M 10-Q · filed 2022-11-07 | $121.20M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $31.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $70.50M 10-Q · filed 2022-08-08 | $94.70M derived: sum of 3 quarters · filed 2023-02-23 | $96.70M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $39.00M 10-Q · filed 2022-05-09 | $63.20M derived: sum of 2 quarters · filed 2023-02-23 | $65.20M derived: sum of 3 quarters · filed 2023-02-23 | $68.20M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $24.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $26.20M derived: sum of 2 quarters · filed 2023-02-23 | $29.20M derived: sum of 3 quarters · filed 2023-02-23 | $52.70M 10-K · filed 2023-02-23 |
| 2020-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $5.00M derived: sum of 2 quarters · filed 2021-11-08 | $28.50M 10-Q · filed 2021-11-08 | $71.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $26.50M 10-Q · filed 2021-08-09 | $69.00M derived: sum of 3 quarters · filed 2022-02-28 | $69.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $23.50M 10-Q · filed 2021-05-06 | $66.00M derived: sum of 2 quarters · filed 2022-02-28 | $66.00M derived: sum of 3 quarters · filed 2022-02-28 | $66.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $42.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $42.50M derived: sum of 2 quarters · filed 2022-02-28 | $42.50M derived: sum of 3 quarters · filed 2022-02-28 | $42.50M 10-K · filed 2022-02-28 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $0.00 derived: sum of 2 quarters · filed 2020-11-10 | $0.00 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $0.00 10-Q · filed 2020-08-11 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-13 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-24 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |